Results 81 to 90 of about 10,160 (227)

Association between hypertensive disorders of pregnancy and placenta accreta spectrum

Pregnancy, Volume 1, Issue 3, May 2025.
Abstract Introduction Placenta accreta spectrum and hypertensive disorders of pregnancy are two significant contributors to severe maternal morbidity and fetal prematurity that may have related but opposite uteroplacental vascular origins. However, the relationship between these conditions is uncertain.
Matthew Givens, Michelle P. Debbink, Lauren H. Theilen, Amanda A. Allshouse, Nathan Blue, Robert M. Silver, Brett D. Einerson   +6 more
wiley   +1 more source

Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives

Experimental Dermatology, Volume 34, Issue 4, April 2025.
ABSTRACT JAK inhibitors are used to treat various inflammatory skin diseases. However, systemic formulations are associated with an increased risk of major adverse events. Ruxolitinib 1.5% cream is a selective topical JAK1 and JAK2 inhibitor, which has recently been approved by EMA and MHRA for treating non‐segmental vitiligo, while being FDA‐approved ...
Marco Spadafora, Serena Morsia, Vito Giuseppe Di Lernia, Shaniko Kaleci, Giovanni Pellacani, Caterina Longo   +5 more
wiley   +1 more source

Lúpus comedônico: rara apresentação do lúpus eritematoso discoide Comedonic lupus: a rare presentation of discoid lupus erythematosus

Anais Brasileiros de Dermatologia, 2011
Lúpus eritematoso cutâneo crônico é doença autoimune, com apresentações polimorfas que podem, eventualmente, mimetizar outras condições clínicas, causando dificuldade diagnóstica.
Daniela Ferro Farias, Roberta Marinho Falcão Gondim, Isabella Portela Redighieri, Helena Muller, Valéria Petri   +4 more
doaj   +1 more source

Current Insights Into The Management Of Discoid Lupus Erythematosus

Clinical, Cosmetic and Investigational Dermatology, 2019
Jaime Company-Quiroga,* Sergio Alique-García,* Alberto Romero-MatéDermatology Department, Fuenlabrada Univesity Hospital, Madrid, Spain*These authors contributed equally to this workCorrespondence: Jaime Company-QuirogaDermatology ...
Company-Quiroga J, Alique-García S, Romero-Maté A   +2 more
doaj  

Drug History and SLE Laboratory Findings Among Iraqi Patients: A Hospital‐Based Study

Health Science Reports, Volume 8, Issue 3, March 2025.
ABSTRACT Background and Aims Systemic lupus erythematosus (SLE) is a recurrent and remitting autoimmune disease that affects many organ systems. It is more common in women of reproductive age, with a 9:1 female preponderance. Due to the lack of data from developing countries, our study aims to provide comprehensive insights into the drug history and ...
Hashim Talib Hashim, Ahmed Dheyaa Al‐Obaidi, Mustafa Najah Al‐Obaidi, Hossam Tharwat Ali, Idris Sula, Hozifa Alfaki, Abdelrahim Elamin, Alaa Hamza Hermis, Assalah Othman, Ahmed Qasim Mohammed Alhatemi   +9 more
wiley   +1 more source

Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus [PDF]

, 2011
Cutaneous manifestations of lupus erythematosus (CLE) are manifold, presenting with unspecific skin manifestations or well-defined clinical dermatological entities.
Sticherling, Michael
core   +3 more sources

Wound, pressure ulcer, and burn guidelines (2023)―4: Guidelines for the management of connective tissue disease/vasculitis‐associated skin ulcers, third edition

The Journal of Dermatology, EarlyView.
Yoshihide Asano, Jun Asai, Takayuki Ishii, Yohei Iwata, Masanari Kodera, Chie Miyabe, Akihiko Uchiyama, Youichi Ogawa, Ken Okamura, Mari Kishibe, Yuta Koike, Yorihisa Kotobuki, Noriki Fujimoto, Takuya Miyagi, Yukie Yamaguchi, Ayumi Yoshizaki, Reiko Omori, Takeshi Nakanishi, Hiroshi Fujiwara, Takeo Maekawa, Sei‐ichiro Motegi, Yuichiro Yoshino, Minoru Hasegawa, Manabu Fujimoto, Takao Tachibana, Wound, Pressure Ulcer, and Burn Guidelines Drafting Committee (connective tissue disease/vasculitis group)   +27 more
wiley   +1 more source

Analysing referral patterns from a primary dermatological clinic to other medical institutions for further care: A survey on patients with certain skin diseases in Japan

JEADV Clinical Practice, Volume 4, Issue 1, Page 181-187, March 2025.
Abstract Background Various skin diseases exist; some require specialist treatment. Consequently, patients with these conditions are often referred from primary dermatological clinics to other medical institutions for further secondary or tertiary care.
Daisuke Ueo, Takashi Sakai, Erika Ochiai, Jun Sese, Yutaka Hatano   +4 more
wiley   +1 more source

Classifying discoid lupus erythematosus: background, gaps, and difficulties

International Journal of Women's Dermatology, 2016
To inform our ongoing efforts to develop defining features to be incorporated into a novel set of classification criteria for discoid lupus erythematosus (DLE), we conducted a literature review using the Ovid MEDLINE database.
Jessica S. Haber, BA, Joseph F. Merola, MD, MMSc, Victoria P. Werth, MD   +2 more
doaj  

Rapid clearance of cutaneous lesions with anifrolumab in SLE (systemic lupus erythematosus) and DLE (discoid lupus erythematosus)

JEADV Clinical Practice, Volume 4, Issue 1, Page 207-215, March 2025.
We treated 6 patients, suffering from SLE or DLE resistant to conventional treatments, with anifrolumab (monoclonal antibody that targets the type 1 interferon receptor subunit 1). The mean CLASI decreased by almost 60% at 1 to 2 months. The mean CLASI score at baseline was 14.2 ± 10.6 (median: 10.5) and decreased to 5.7 ± 5.3 (median: 3.0) after one ...
E. Parriel, C. Bulai‐Livideanu, M. Severino‐Freire, A. Delpuech, S. Faguer, J. Belliere, A. Huart, C. Paul   +7 more
wiley   +1 more source